This study will retrospectively review and compare clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
Composite of stroke and major bleeding will be compared after adjusting those groups using inverse probability weighted model.
Study Type
OBSERVATIONAL
Enrollment
480
Left atrial appnedage occlusion using ACP or Watchman
Composite of stroke and major bleeding
Primary endpoint is a composite of stroke and major bleeding. Stroke is defined as ischemic cerebrovascular event included both transient ischemic attack and ischemic cerebral infarction. Major bleeding event was defined as moderate or severe bleeding according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries criteria.
Time frame: From date of index procedure until the date of primary endpoint occur or date of last follow up, whichever came first, assessed up to 50 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.